Mild exercise activates renal dopamine system in mild hypertensives

Journal of Human Hypertension

Volumn 12, Issue 6, 1998, Pages 355-362

  Sakai, T ^a   Ideishi, M ^a   Miura, S ^a   Maeda, H ^a   Tashiro, E ^a   Koga, M ^a   Kinoshita, A ^a   Sasaguri, M ^a   Tanaka, H ^a   Shindo, M ^a   Arakawa, K ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Aromatic L amino acid decarboxylase; Blood pressure; Essential hypertension; Exercise therapy; Urinary free dopamine; Urinary kallikrein activity

Indexed keywords

BRADYKININ; CATECHOLAMINE DERIVATIVE; DOPA; DOPAMINE; KALLIKREIN; LACTIC ACID; NORADRENALIN; POTASSIUM; SODIUM;

ADULT; ARTICLE; BICYCLE ERGOMETRY; BODY WEIGHT; BORDERLINE HYPERTENSION; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECARBOXYLATION; DIASTOLIC BLOOD PRESSURE; DOPAMINE URINE LEVEL; DOPAMINERGIC SYSTEM; EXERCISE; FEMALE; HEART RATE; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; KALLIKREIN KININ SYSTEM; KALLIKREIN URINE LEVEL; KIDNEY; KINESIOTHERAPY; LACTATE BLOOD LEVEL; MALE; NATRIURESIS; NORADRENALIN BLOOD LEVEL; NORADRENALIN URINE LEVEL; PLASMA VOLUME; POTASSIUM URINE LEVEL; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE;

EID: 7344242138     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000608     Document Type: Article

References (43)

1. World Hypertension League. Physical exercise in the management of hypertension. Bull WHO 1991; 69: 149-153.
2. Joint National Committee. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153: 154-183.
3. Arakawa K, Kiyonaga A, Tanaka H, Shindo M. Antihypertensive effect of aerobic exercise therapy and plasma renin activity [abstract]. Circulation. 1984; 70 (Suppl II): II63.
4. Arakawa K. Antihypertensive mechanism of exercise. J Hypertens 1993; 11: 223-229.
5. Kiyonaga A, Arakawa K, Tanaka H, Shindo M. Blood pressure and humoral response to aerobic exercise. Hypertension 1985; 6: 125-131.
6. Urata H et al. Antihypertensive and volume-depleting effects of mild exercise on essential hypertension. Hypertension 1987; 9: 245-252.
7. Hagberg JM, Montain SJ, Martin WH, Ehsani AA. Effect of exercise training in 60- to 69-year-old persons with essential hypertension. Am J Cardiol 1989; 64: 348-353.
8. Nelson L, Jennings GL, Esler MD, Korner PI. Effect of changing levels of physical activity on blood-pressure and haemodynamics in essential hypertension. Lancet 1986; ii: 473-476.
9. Duncan JJ et al. The effect of aerobic exercise on plasma catecholamines and blood pressure in patients with mild essential hypertension. JAMA 1985; 254: 2609-2613.
10. Meredith IT et al. Time-course of the antihypertensive and autonomic effects of regular endurance exercise in human subjects. J Hypertens 1990; 8: 859-866.
11. Meredith IT et al. Exercise training lowers resting renal but not cardiac sympathetic activity in humans. Hypertension 1991; 18: 575-582.
12. Tanabe Y et al. Changes in serum concentrations of taurine and other amino acids in clinical antihypertensive exercise therapy. Clin Exp Hypertens 1989; A11: 149-165.
13. Kinoshita A et al. Changes of dopamine and atrial natriuretic factor by mild exercise therapy for hypertensives. Clin Exp Hypertens 1991; A13: 1275-1290.
14. Koga M et al. Mild exercise decreases plasma endogenous digitalislike substance in hypertensive individuals. Hypertension 1992; 19 (Suppl II): II231-II236.
15. Miura S et al. Urinary kallikrein activity is increased during the first few weeks of exercise training in essential hypertension. J Hypertens 1994; 12: 815-823.
16. Iimura O et al. The pathophysiological role of renal dopamine, kallikrein/kinin and prostaglandin systems in essential hypertension. Agents Actions 1987; 22: 247-256.
17. Aoki K et al. Attenuated renal production of dopamine in patients with low renin essential hypertension. Clin Exp Hypertens 1989; A11 (Suppl 1): 403-409.
18. Lee MR. Dopamine and the kidney: ten years on. Clin Sci 1993; 84: 357-375.
19. Hubbard PC, Henderson IW. Renal dopamine and the tubular handling of sodium. J Mol Endocrinol 1995; 14: 139-155.
20. Kuchel O et al. Free and conjugated plasma and urinary dopamine in human hypertension. J Clin Endocrinol Metab 1979; 48: 425-429.
21. Robertson PS et al. A computerized dichromatic earpiece densitometer for measurement of cardiac output. Cardiovas Res 1979; 13: 420-426.
22. Crispell KR, Porter B, Nieset RT. Studies of plasma volume using human serum albumin tagged with radioactive iodine. J Clin Invest 1985; 29: 513-516.
23. Tochikubo O, Uneda S, Kaneko Y. Simple portable device for sampling a whole day's urine and its application to hypertensive outpatients. Hypertension 1983; 5: 270-274.
24. Ratge D, Gehrke A, Melzner I, Wisser H. Free and conjugated catecholamines in human plasma during physical exercise. Clin Exp Pharmacol Physiol 1986; 13: 543-553.
25. Sakai T et al. Plasma free and sulfoconjugated dopamine before and after a half-marathon. Hypertens Res 1995; 18 (Suppl I): S161-S163.
26. Yoshizumi M et al. Changes in plasma free and sulfoconjugated catecholamines before and after acute physical exercise: experimental and clinical studies. Life Sci 1992; 51: 227-234.
27. Margolius HS, Geller R, Pisano JJ, Sjoerdsma A. Altered urinary kallikrein excretion in human hypertension. Lancet 1997; ii: 1063-1065.
28. Iimura O. Pathophysiological significance of sympathetic function in essential hypertension. Clin Exp Hypertens 1989; A11 (Suppl 1): 103-115.
29. Lee MR. Dopamine and kidney. Clin Sci 1982; 62: 439-448.
30. Hjemdahl P, Bradley T, Tidgren B. Release of dopamine from canine and human kidneys in vivo. In: Bell C, McGrath B (eds). Peripheral Actions of Dopamine. Macmillan: London, 1988, pp 56-74.
31. Jeffrey RF, Macdonald TM, Lee MR. A comparison of the renal actions of γ-L-glutamyl-L-dopa and γ-L-glutamyl-L-tyrosine in normal man. Clin Sci 1988; 74: 37-49.
32. Soares-da-Silva P, Fernandes MH. Regulation of dopamine synthesis in the rat kidney. J Auton Pharmacol 1990; 10 (Suppl I): S25-S30.
33. Hagège J, Richet G. Proximal tubule dopamine histofluorescence in renal slices incubated with L-dopa. Kidney Int 1985; 27: 3-8.
34. Baines AD, Chan W. Production of urine free dopamine from DOPA: a micropuncture study. Life Sci 1980; 26: 253-259.
35. Stephenson RK, Sole MJ, Baines AD. Neural and extraneural catecholamine production by rat kidneys. Am J Physiol 1982; 242: F261-F266.
36. Hayashi M, Yamaji Y, Kitajima W, Saruta T. Aromatic L-amino acid decarboxylase activity along the rat nephron. Am J Physiol 1990; 258: F28-F33.
37. Cuche JL et al. Relationship between the adrenergic nervous system and renin during adaptation to upright posture: a possible role for 3,4-dihydroxyphenylalanine (dopamine). Clin Sci 1972; 43: 481-491.
38. Lee MR. Dopamine and the kidney. In: Lote CJ (ed). Advances in renal physiology. Croom Helm: London and Sydney, 1986, pp 218-246.
39. Hayashi M, Yamaji Y, Kitajima W, Saruta T. Effects of high salt intake on dopamine production in rat kidney. Am J Physiol 1991; 260: E675-E679.
40. Ball SG, Lee MR. The effect of carbidopa administration on urinary sodium excretion in man. Is dopamine an intrarenal natriuretic hormone? Br J Clin Pharmacol 1977; 4: 115-119.
41. Jeffrey RF, MacDonald TM, Marwick K, Lee MR. The effect of carbidopa and indomethacin on the renal response to γ-L-glutamyl-L-dopa in normal man. Br J Clin Pharmacol 1988; 25: 195-201.
42. Goldstein DS, Stull R, Eisenhofer G, Gill JR, Jr. Urinary excretion of dihydroxyphenylalanine and dopamine during alterations of dietary salt intake in humans. Clin Sci 1989; 76: 517-522.
43. +-ATPaSe activity in rat proximal convoluted tubule segments. Am J Physiol 1987; 252: F39-F45.